# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA615544 | F | Stimulation of adipogenesis in 3T3-L1 cells is expressed as concentration equivalent to the [ 1-14C] uptake counts after treatment with 0.2 ug/mL troglitazone | Mus musculus | 25 | ALA1133611 | cell-based format | Scientific Literature | |
2. | ALA615545 | F | Effective concentration for enhancement of insulin-induced triglyceride accumulation in 3T3-L1 cells | Mus musculus | 8 | ALA1136279 | cell-based format | Scientific Literature | |
3. | ALA615547 | F | Percentage of rosiglitazone response for insulin-sensitizing activity at 1 uM concentration in 3T3-L1 cells | Mus musculus | 15 | ALA1136279 | cell-based format | Scientific Literature | |
4. | ALA618701 | A | Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats | Rattus norvegicus | 4 | ALA1136679 | organism-based format | Scientific Literature | |
5. | ALA618713 | A | Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound | Rattus norvegicus | 7 | ALA1136170 | organism-based format | Scientific Literature | |
6. | ALA626857 | A | Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg) | Rattus norvegicus | 7 | ALA1136397 | organism-based format | Scientific Literature | |
7. | ALA621958 | A | Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg | Rattus norvegicus | 6 | ALA1136170 | organism-based format | Scientific Literature | |
8. | ALA628646 | A | Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats | Rattus norvegicus | 4 | ALA1136679 | organism-based format | Scientific Literature | |
9. | ALA628647 | A | Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg) | Rattus norvegicus | 8 | ALA1136397 | organism-based format | Scientific Literature | |
10. | ALA626259 | A | Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v. | Rattus norvegicus | 7 | ALA1136170 | organism-based format | Scientific Literature | |
11. | ALA627490 | A | Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats | Rattus norvegicus | 5 | ALA1136679 | organism-based format | Scientific Literature | |
12. | ALA873829 | A | Half-life was determined in rat after intravenous administration (0.5 mg/kg) | Rattus norvegicus | 8 | ALA1136397 | organism-based format | Scientific Literature | |
13. | ALA626376 | A | Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg) | Rattus norvegicus | 6 | ALA1136170 | organism-based format | Scientific Literature | |
14. | ALA624750 | A | Oral bioavailability in rat (dose 2 mg/kg) | Rattus norvegicus | 8 | ALA1136397 | organism-based format | Scientific Literature | |
15. | ALA620475 | A | Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg) | Rattus norvegicus | 5 | ALA1136679 | organism-based format | Scientific Literature | |
16. | ALA631233 | P | Hydrophilicity was determined | 4 | ALA1150042 | small-molecule physicochemical format | Scientific Literature | ||
17. | ALA631423 | P | Calculated partition coefficient (clogP) | 20 | ALA1131213 | small-molecule physicochemical format | Scientific Literature | ||
18. | ALA634496 | A | Clearance after oral administration | 3 | ALA1135600 | organism-based format | Scientific Literature | ||
19. | ALA634499 | A | Clearance in rat | Rattus norvegicus | 6 | ALA1145887 | organism-based format | Scientific Literature | |
20. | ALA637058 | A | Area under plasma concentration time curve after oral administration at a dose 2.2 mg/kg | 3 | ALA1135600 | organism-based format | Scientific Literature |